| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3292257 | Gastroenterology | 2015 | 14 Pages |
Abstract
FMT induces remission in a significantly greater percentage of patients with active UC than placebo, with no difference in adverse events. Fecal donor and time of UC appear to affect outcomes. ClinicalTrials.gov Number: NCT01545908.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Paul Moayyedi, Michael G. Surette, Peter T. Kim, Josie Libertucci, Melanie Wolfe, Catherine Onischi, David Armstrong, John K. Marshall, Zain Kassam, Walter Reinisch, Christine H. Lee,